Clinical Trial

Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System

Recruiting
View on ClinicalTrials.gov →
Summary
The objective of the study is to assess the safety and technical feasibility of the Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
Protocol Amendment History 4 changes
notable Enrollment increased: 45 -> 65 participants 2026-07-24
notable Trial sites expanded: 6 -> 10 locations 2026-07-24
notable Primary completion pushed: 2025-12 -> 2027-12 2026-07-24
minor Completion pushed: 2030-12 -> 2032-12 2026-07-24
Trial Details
NCT Number NCT06183684
Lead Sponsor Laplace Interventional, Inc
Conditions Tricuspid Regurgitation
Enrollment 65 participants
Start Date 2024-02-19
Primary Completion 2027-12 (estimated)
Study Completion 2032-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-23